文献速递肿瘤 PET/CT

非对映异构体纯的6R-和6S-3'-氮杂-2'-18F-氟-5-甲基四氢叶酸在叶酸受体阳性KB肿瘤中显示空前高的摄取

Diastereomerically Pure 6R- and 6S-3'-Aza-2'-18F-Fluoro-5-Methyltetrahydrofolates Show Unprecedentedly High Uptake in Folate Receptor-Positive KB Tumors.
PubMed 文献 · J Nucl Med · 2018-07-24

本研究采用整合方法放射合成非对映异构体纯的6R-18F-1和6S-18F-1,并在叶酸受体α阳性KB细胞及荷瘤小鼠中与氧化型18F-2比较体外和体内性能。结果显示两种还原型示踪剂在注射后180分钟肿瘤摄取均超过32%ID/g,而18F-2仅15%ID/g,PET/CT显像均优于18F-2。

要点

  • 6R-18F-1和6S-18F-1在KB肿瘤中180分钟摄取均超过32%ID/g,18F-2为15%ID/g。
  • 两种还原型示踪剂在KB肿瘤PET/CT显像中均优于氧化型18F-2。
  • 作者认为6R-和6S-18F-1是用于显像FR-α表达肿瘤的有前景的还原型放射性叶酸。

核心结论

  • 作者成功用整合方法将6R-和6S-3'-氮杂-2'-18F-氟-5-甲基四氢叶酸进行18F放射标记。
  • 作者认为6R-18F-1和6S-18F-1是用于显像FR-α表达肿瘤的有前景的还原型放射性叶酸。

研究设计与样本

  • 本研究旨在开发非对映异构体纯的6R-18F-1和6S-18F-1的放射合成,并与先前报道的氧化型3'-氮杂-2'-18F-氟叶酸示踪剂18F-2比较体外和体内性能。
  • 使用表达叶酸受体α的KB细胞进行体外细胞摄取研究和结合亲和力测定。
  • 使用荷KB肿瘤小鼠进行PET/CT显像和生物分布实验。

主要发现

  • 参考化合物6R-1和6S-1经相应保护中间体6R-3和6S-3酸水解获得,化学产率高(81%-87%),化学纯度超过95%。
  • 6R-18F-1、6S-18F-1和18F-2经两步放射合成步骤获得,衰变校正放射化学产率高达5%,摩尔放射性活度为20至250 GBq/μmol。
  • 在FR-α阳性KB细胞中,6R-1和6S-1的半最大抑制浓度分别为27.1 ± 3.7和23.8 ± 4.0 nM,均高于先前报道的3'-氮杂-2'-氟叶酸2(1.4 ± 0.5 nM)。
  • 在注射后180分钟,6R-18F-1和6S-18F-1在KB肿瘤中摄取均超过每克组织注射活性的32%,而18F-2在KB肿瘤中仅为每克组织注射活性的15%。
  • 6R-和6S-非对映异构体与18F-2在肾脏、肝脏、唾液腺和脾脏中的放射性摄取存在显著差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The aim of this study was to develop the radiosyntheses of diastereomerically pure 6R- and 6S-3'-aza-2'-18F-fluoro-5-methyltetrahydrofolate (MTHF) (6R-18F-1 and 6S-18F-1) using the integrated approach and to compare the in vitro and in vivo performance characteristics of both radioligands with the previously reported 3'-aza-2'-18F-fluorofolic acid tracer (18F-2), the oxidized form. Methods: 6R-18F-1, 6S-18F-1, and 18F-2 were radiolabeled with 18F using aromatic nucleophilic substitution reaction. In vitro cell uptake studies and binding affinity assays were performed using folate receptor (FR)-α-expressing KB cells. PET/CT imaging and biodistribution experiments were performed with KB tumor-bearing mice. Results: Reference compounds 6R-1 and 6S-1 were obtained after acidic hydrolysis of the corresponding protected intermediates 6R-3 and 6S-3 in high chemical yields (81%-87%) and chemical purities of more than 95%. 6R-18F-1, 6S-18F-1, and 18F-2 were obtained after a 2-step radiosynthetic procedure in a decay-corrected radiochemical yield of up to 5% and molar radioactivities ranging from 20 to 250 GBq/μmol. In vitro binding affinity studies using FR-α-positive KB cells gave half-maximal inhibitory concentrations of 27.1 ± 3.7 and 23.8 ± 4.0 nM for 6R-1 and 6S-1, respectively, which were higher than for the previously reported 3'-aza-2'-fluorofolic acid 2 (1.4 ± 0.5 nM). Comparably high cell uptake values in FR-α-expressing KB cells were found for all 3 radiofolates. In biodistribution studies, exceptionally high KB tumor uptake value of over 32% injected activity per gram of tissue for both 6R-18F-1 and 6S-18F-1 was observed at 180 min after injection, whereas for 18F-2 only 15% injected activity per gram was found in the KB tumors. Radioactivity uptake in the kidneys, liver, salivary glands, and spleen was substantially different for the 6R- and 6S-diastereoisomers and 18F-2 Excellent KB tumor visualization was found in PET/CT images with 6R-18F-1 and 6S-18F-1, both of which outperformed the corresponding oxidized 18F-2. Conclusion: We have successfully radiolabeled 6R- and 6S-3'-aza-2'-18F-fluoro-5-MTHF with 18F using the integrated approach. Our results suggest that both 6R- and 6S-3'-aza-2'-18F-fluoro-5-MTHF are promising reduced radiofolates for imaging FR-α-expressing cancers.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Boss SD, Müller C, Siwowska K, et al. Diastereomerically Pure 6R- and 6S-3'-Aza-2'-18F-Fluoro-5-Methyltetrahydrofolates Show Unprecedentedly High Uptake in Folate Receptor-Positive KB Tumors. J Nucl Med. 2018. PMID: 30042162. doi:10.2967/jnumed.118.213314

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。